Joseph A Landolina

Title: Joseph A. Landolina: Innovator in Hemostatic Adhesive Technologies

Introduction

Joseph A. Landolina is a prominent inventor based in Pine Bush, NY (US). He has made significant contributions to the field of biocompatible polymer technologies, particularly in the development of hemostatic adhesive devices. With a total of 5 patents to his name, Landolina's work has the potential to revolutionize medical practices related to wound care and hemostasis.

Latest Patents

One of his latest patents is titled "Highly efficacious hemostatic adhesive polymer scaffold." This invention relates to biocompatible polymer gel compositions that facilitate and maintain hemostasis. The composition includes one or more polyanionic polymers, one or more polycationic polymers, and a solvent. A preferred formulation consists of sodium alginate, chitosan, and water, which together create an adhesive hemostatic device that promotes rapid hemostasis.

Another notable patent is "In-situ cross-linkable polymeric compositions and methods thereof." This biocompatible polymeric composition is designed for cross-linking in-situ within a wound. It comprises one or more polyanionic polymers, such as alginates or hyaluronates, and one or more polycationic polymers, such as chitosan or DEAE-Dextran. This innovative composition aids in solidification and accelerates hemostasis without the need for external pressure. Additionally, it may include a cross-linking agent like aqueous calcium chloride.

Career Highlights

Joseph A. Landolina has worked with notable companies, including Cresilon, Inc. and Cresilion, Inc. His expertise in polymer science and wound care has positioned him as a leader in the development of advanced medical technologies.

Collaborations

Throughout his career, Landolina has collaborated with talented individuals such as Omar M. Ahmad and Jonathan David Lee. These partnerships have contributed to the advancement of his innovative projects and patents.

Conclusion

Joseph A. Landolina's contributions to the field of hemostatic adhesive technologies demonstrate his commitment to improving medical outcomes through innovation. His patents reflect a deep understanding of biocompatible materials and their applications in wound care.